UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Interaction of medicines for pharmacotherapy of anxiety disorders with comorbidal pathology of gastrointestinal tract

Type of Article

In the Section

Index UDK:

Abstract

The authors analyzed and summarized the information on the interaction of drugs, as well as identifi ed groups of gastroenterological patients who require careful monitoring during combination pharmacotherapy of anxiety disorders against in the background of diseases of the gastrointestinal tract.

Pages

References

  1. Mental disorders in gastroenterology [Electronic resource] // Meginkarew.ru : [Website]. URL : http://meginkarew.ru/vidpoved/7566-psihichni-rozladi-v-gastroenterologii.html  (date of access: 16.04.2018). Title from screen.
  2. Cytochrome P450 (isoenzymes CYP2C19 and CYP3A4) [Electronic resource] // Functional Gastroenterology: [Website] / IstokSystem CJSC. URL: http://www.gastroscan.ru/handbook/117/3504  (accessed on 16.04.2018). Title from the screen.
  3. Belousov, Yu. B., Gurevich K. G. Clinical Pharmacokinetics. The Practice of Drug Dosage. Moscow: Littera, 2005. 288 p.
  4. Ables, A. Z., Nagubilli R. Prevention, recognition, and management of serotonin // Am. Fam. Physician. 2010. Vol. 81, № 9. P. 1139—1142.
  5. Margetić, B., Aukst-Margetić B. Neuroleptic malignant syndrome and its controversies // Pharmacoepidemiol. Drug Saf. 2010. Vol. 19, № 5. P. 429—435.
  6. Medscape [Electronic resource]. N.Y., 1994–2018. URL: https://reference.medscape.com/drugs  (date of access: 16.04.2018). Title from screen.
  7. Compendium: Medicinal Products [Electronic resource]. Kyiv: Morion, 1999–2018. URL: https://compendium.com.ua (accessed on 16.04.2018). Title from the screen.
  8. Search for medicines in pharmacies [Electronic resource] // Tabletki. ua :  [Website]. Kyiv, 2010—2018. URL  : https://tabletki.ua   (accessed on 16.04.2018). Title from the screen.
  9. Bordin, D. S. Safety of treatment as a criterion for selecting a proton pump inhibitor for patients with gastroesophageal reflux disease // Consilium Medicum. 2010. Vol. 12, No. 8. Pp. 77–81.